Dr. Jie Tang 唐洁
Chief Physician
Department of Gynecologic Oncology, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Ovarian cancer, endometrial cancer, and cervical cancer.
Dr. Tang is a Chief Physician with a US doctorate and postdoctoral training. After seven years in the US, including clinical work at Albert Einstein Hospital, Thomas Jefferson University, Dr. Tang holds a US medical license. With over ten years of experience, Dr. Tang specializes in gynecologic oncology surgery, including vaginal, laparoscopic, single-port laparoscopic, and robotic techniques, as well as pelvic floor reconstruction. Dr. Tang has led NIH-funded projects and published over ten first-author SCI papers.
Professional roles
- Reviewer, Clinical Cancer Research
Name order: in Chinese the family name comes first (Tang Jie). Papers usually list the name as Jie Tang or Tang J.
Selected publications
31 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Gynecol Oncol Rep, 2025 (senior author): Patient with HR-proficient advanced ovarian cancer achieved a complete response with Cadonilimab combined chemotherapy (PD-1/CTLA-4 bispecific): a case report and literature review. PubMed 40600147
- Ann Surg Oncol, 2025 (senior author): ASO Author Reflections: Laparoscopic Radical Hysterectomy has Equivalent Survival Outcomes Compared with Open Abdominal Radical Hysterectomy in Early-Stage Low-Risk Cervical Cancer. PubMed 40399600
- Ann Surg Oncol, 2025 (senior author): Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer Patients: A Multi-Center Study with 10 Years' Experiences in the Real World. PubMed 39739265
- J Transl Med, 2023 (senior author): Circulating small extracellular vesicles microRNAs plus CA-125 for treatment stratification in advanced ovarian cancer. PubMed 38129848
- Front Cell Dev Biol, 2022 (senior author): Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. PubMed 36712973
- Front Bioeng Biotechnol, 2022 (senior author): Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer. PubMed 35662846
- Exp Cell Res, 2022 (senior author): Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer. PubMed 34875218
- Mol Ther Nucleic Acids, 2021 (senior author): lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress. PubMed 33850634
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion